{"transactions":[{"id":1665211,"issuer":{"id":1939,"kind":"organization","name":"Apogee Therapeutics, Inc.","symbol":"APGE"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":92444,"kind":"person","name":"Fairmount Healthcare Fund L.P.","position":2,"cik":"0001686157","reported_name":"Fairmount Healthcare Fund L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2223,"kind":"person","name":"Fairmount Healthcare Fund II L.P.","position":3,"cik":"0001769651","reported_name":"Fairmount Healthcare Fund II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94756,"kind":"person","name":"Fairmount Healthcare Co-Invest II L.P.","position":4,"cik":"0001982189","reported_name":"Fairmount Healthcare Co-Invest II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2224,"kind":"person","name":"Kiselak Tomas","position":5,"cik":"0001830177","reported_name":"Kiselak Tomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":6,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T16:31:31.000Z","date":"2024-01-29","kind":"other","planned":true,"acquired":true,"shares":51166,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Peter Harwin"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP (\"Co-Invest\") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023."}],"balance_after":51166,"source":{"system":"sec-edgar","filing":"0001104659-24-008835","document":"tm244753-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1686157/000110465924008835/tm244753-2_4seq1.xml","form_type":"4"}},{"id":1665210,"issuer":{"id":1939,"kind":"organization","name":"Apogee Therapeutics, Inc.","symbol":"APGE"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":92444,"kind":"person","name":"Fairmount Healthcare Fund L.P.","position":2,"cik":"0001686157","reported_name":"Fairmount Healthcare Fund L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2223,"kind":"person","name":"Fairmount Healthcare Fund II L.P.","position":3,"cik":"0001769651","reported_name":"Fairmount Healthcare Fund II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94756,"kind":"person","name":"Fairmount Healthcare Co-Invest II L.P.","position":4,"cik":"0001982189","reported_name":"Fairmount Healthcare Co-Invest II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2224,"kind":"person","name":"Kiselak Tomas","position":5,"cik":"0001830177","reported_name":"Kiselak Tomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":6,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T16:31:31.000Z","date":"2024-01-29","kind":"other","planned":true,"acquired":true,"shares":51166,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tomas Kiselak"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP (\"Co-Invest\") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023."}],"balance_after":51166,"source":{"system":"sec-edgar","filing":"0001104659-24-008835","document":"tm244753-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686157/000110465924008835/tm244753-2_4seq1.xml","form_type":"4"}},{"id":1665209,"issuer":{"id":1939,"kind":"organization","name":"Apogee Therapeutics, Inc.","symbol":"APGE"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":92444,"kind":"person","name":"Fairmount Healthcare Fund L.P.","position":2,"cik":"0001686157","reported_name":"Fairmount Healthcare Fund L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2223,"kind":"person","name":"Fairmount Healthcare Fund II L.P.","position":3,"cik":"0001769651","reported_name":"Fairmount Healthcare Fund II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94756,"kind":"person","name":"Fairmount Healthcare Co-Invest II L.P.","position":4,"cik":"0001982189","reported_name":"Fairmount Healthcare Co-Invest II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2224,"kind":"person","name":"Kiselak Tomas","position":5,"cik":"0001830177","reported_name":"Kiselak Tomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":6,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T16:31:31.000Z","date":"2024-01-29","kind":"other","planned":true,"acquired":false,"shares":892529,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fairmount Healthcare Co-Invest II LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP (\"Co-Invest\") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC (\"Fairmount\") is the investment manager for Fairmount Healthcare Fund L.P. (\"Fund I\"), Fairmount Healthcare Fund II L.P. (\"Fund II\") and Co-Invest. The general partner of Fairmount is Fairmount Funds Management GP LLC (\"Fairmount GP\"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-008835","document":"tm244753-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686157/000110465924008835/tm244753-2_4seq1.xml","form_type":"4"}},{"id":1828691,"issuer":{"id":1939,"kind":"organization","name":"Apogee Therapeutics, Inc.","symbol":"APGE"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":92444,"kind":"person","name":"Fairmount Healthcare Fund L.P.","position":2,"cik":"0001686157","reported_name":"Fairmount Healthcare Fund L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2223,"kind":"person","name":"Fairmount Healthcare Fund II L.P.","position":3,"cik":"0001769651","reported_name":"Fairmount Healthcare Fund II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94756,"kind":"person","name":"Fairmount Healthcare Co-Invest II L.P.","position":4,"cik":"0001982189","reported_name":"Fairmount Healthcare Co-Invest II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2224,"kind":"person","name":"Kiselak Tomas","position":5,"cik":"0001830177","reported_name":"Kiselak Tomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":6,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-17T20:00:23.000Z","date":"2023-07-13","kind":"grant","planned":false,"acquired":true,"shares":47758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 47,758 shares of the Issuer's common stock, and will vest in three approximately equal annual installments beginning on the first anniversary of the grant date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Under Mr. Kiselak's arrangement with Fairmount, Mr. Kiselak holds the option for one or more Fairmount Funds. Mr. Kiselak is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Kiselak therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":47758,"derivative":{"exercise_price":17,"expiration_date":"2033-07-13","underlying":"Common Stock","underlying_shares":47758},"source":{"system":"sec-edgar","filing":"0001104659-23-081729","document":"tm2321456-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1686157/000110465923081729/tm2321456-6_4seq1.xml","form_type":"4"}},{"id":1828690,"issuer":{"id":1939,"kind":"organization","name":"Apogee Therapeutics, Inc.","symbol":"APGE"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":92444,"kind":"person","name":"Fairmount Healthcare Fund L.P.","position":2,"cik":"0001686157","reported_name":"Fairmount Healthcare Fund L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2223,"kind":"person","name":"Fairmount Healthcare Fund II L.P.","position":3,"cik":"0001769651","reported_name":"Fairmount Healthcare Fund II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94756,"kind":"person","name":"Fairmount Healthcare Co-Invest II L.P.","position":4,"cik":"0001982189","reported_name":"Fairmount Healthcare Co-Invest II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2224,"kind":"person","name":"Kiselak Tomas","position":5,"cik":"0001830177","reported_name":"Kiselak Tomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":6,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-17T20:00:23.000Z","date":"2023-07-13","kind":"grant","planned":false,"acquired":true,"shares":47758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 47,758 shares of the Issuer's common stock, and will vest in three approximately equal annual installments beginning on the first anniversary of the grant date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Under Mr. Harwin's arrangement with Fairmount, Mr. Harwin holds the option for one or more investment vehicles managed by Fairmount (each, a \"Fairmount Fund\"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":47758,"derivative":{"exercise_price":17,"expiration_date":"2033-07-13","underlying":"Common Stock","underlying_shares":47758},"source":{"system":"sec-edgar","filing":"0001104659-23-081729","document":"tm2321456-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1686157/000110465923081729/tm2321456-6_4seq1.xml","form_type":"4"}},{"id":1828689,"issuer":{"id":1939,"kind":"organization","name":"Apogee Therapeutics, Inc.","symbol":"APGE"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":92444,"kind":"person","name":"Fairmount Healthcare Fund L.P.","position":2,"cik":"0001686157","reported_name":"Fairmount Healthcare Fund L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2223,"kind":"person","name":"Fairmount Healthcare Fund II L.P.","position":3,"cik":"0001769651","reported_name":"Fairmount Healthcare Fund II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94756,"kind":"person","name":"Fairmount Healthcare Co-Invest II L.P.","position":4,"cik":"0001982189","reported_name":"Fairmount Healthcare Co-Invest II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2224,"kind":"person","name":"Kiselak Tomas","position":5,"cik":"0001830177","reported_name":"Kiselak Tomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":6,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-17T20:00:23.000Z","date":"2023-07-13","kind":"purchase","planned":false,"acquired":true,"shares":892529,"price":17,"value":15172993.0,"ownership":{"direct":false,"nature":"By Fairmount Healthcare Co-Invest II LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Fairmount Funds Management LLC (\"Fairmount\") is the investment manager for Fairmount Healthcare Fund LP, Fairmount Healthcare Fund II LP and Fairmount Healthcare Co-Invest II LP. The general partner of Fairmount is Fairmount Funds Management GP LLC (\"Fairmount GP\"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":892529,"source":{"system":"sec-edgar","filing":"0001104659-23-081729","document":"tm2321456-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1686157/000110465923081729/tm2321456-6_4seq1.xml","form_type":"4"}},{"id":1828688,"issuer":{"id":1939,"kind":"organization","name":"Apogee Therapeutics, Inc.","symbol":"APGE"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":92444,"kind":"person","name":"Fairmount Healthcare Fund L.P.","position":2,"cik":"0001686157","reported_name":"Fairmount Healthcare Fund L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2223,"kind":"person","name":"Fairmount Healthcare Fund II L.P.","position":3,"cik":"0001769651","reported_name":"Fairmount Healthcare Fund II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94756,"kind":"person","name":"Fairmount Healthcare Co-Invest II L.P.","position":4,"cik":"0001982189","reported_name":"Fairmount Healthcare Co-Invest II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2224,"kind":"person","name":"Kiselak Tomas","position":5,"cik":"0001830177","reported_name":"Kiselak Tomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":6,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-17T20:00:23.000Z","date":"2023-07-13","kind":"purchase","planned":false,"acquired":true,"shares":1992734,"price":17,"value":33876478.0,"ownership":{"direct":false,"nature":"By Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Fairmount Funds Management LLC (\"Fairmount\") is the investment manager for Fairmount Healthcare Fund LP, Fairmount Healthcare Fund II LP and Fairmount Healthcare Co-Invest II LP. The general partner of Fairmount is Fairmount Funds Management GP LLC (\"Fairmount GP\"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":1992734,"source":{"system":"sec-edgar","filing":"0001104659-23-081729","document":"tm2321456-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686157/000110465923081729/tm2321456-6_4seq1.xml","form_type":"4"}},{"id":1828687,"issuer":{"id":1939,"kind":"organization","name":"Apogee Therapeutics, Inc.","symbol":"APGE"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":92444,"kind":"person","name":"Fairmount Healthcare Fund L.P.","position":2,"cik":"0001686157","reported_name":"Fairmount Healthcare Fund L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2223,"kind":"person","name":"Fairmount Healthcare Fund II L.P.","position":3,"cik":"0001769651","reported_name":"Fairmount Healthcare Fund II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94756,"kind":"person","name":"Fairmount Healthcare Co-Invest II L.P.","position":4,"cik":"0001982189","reported_name":"Fairmount Healthcare Co-Invest II L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2224,"kind":"person","name":"Kiselak Tomas","position":5,"cik":"0001830177","reported_name":"Kiselak Tomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":6,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-17T20:00:23.000Z","date":"2023-07-13","kind":"purchase","planned":false,"acquired":true,"shares":55913,"price":17,"value":950521.0,"ownership":{"direct":false,"nature":"By Fairmount Healthcare Fund LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Fairmount Funds Management LLC (\"Fairmount\") is the investment manager for Fairmount Healthcare Fund LP, Fairmount Healthcare Fund II LP and Fairmount Healthcare Co-Invest II LP. The general partner of Fairmount is Fairmount Funds Management GP LLC (\"Fairmount GP\"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":55913,"source":{"system":"sec-edgar","filing":"0001104659-23-081729","document":"tm2321456-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686157/000110465923081729/tm2321456-6_4seq1.xml","form_type":"4"}}]}